PHARMACOLOGY AND THERAPEUTICS OF ASTHMA AND COPD (HB 2017)

PAGE C P

ISBN 10: 331952173X / ISBN 13: 9783319521732

Published by SPRINGER, 2017

About this Item

Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 7-12 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.

Seller Inventory # CVS 9783319521732

Bibliographic Details

• Title: PHARMACOLOGY AND THERAPEUTICS OF ASTHMA AND COPD (HB 2017)
• Publisher: SPRINGER
• Publication Date: 2017
• Language: English
• ISBN 10: 331952173X
• ISBN 13: 9783319521732
• Binding: Hardcover
• Edition: International Edition
• Condition: New

About this title

Synopsis

The present volume is supposed to be a major reference resource for chest physicians and those involved in the development of novel pharmaceutical entities for these diseases. Internationally recognized authorities review the most important new information on the advances in our understanding of the pathogenesis and treatment of these diseases, including the substantial advances in the topical delivery of inhaled medicines. Each chapter is extensively referenced, generously illustrated with clear diagrams and photographs, and represents a state-of-the-art review of this important area of respiratory medicine.

Review

“This is an excellent guide to help readers understand the thinking behind management choices in asthma and chronic obstructive pulmonary disease. ... This book, written by a respected group of international authors, will provide a valuable reference for both primary and secondary care clinicians as well as allied health professionals and students who are looking for succinct, up-to-date information to help them treat patients with asthma or chronic obstructive pulmonary disease.” (J. K. Quint, British Journal of Hospital Medicine, Vol. 78 (5), May, 2017)